DurAVR THV

Anteris Raises $200M to Advance Global Heart Valve Trial

Minneapolis, U.S., and Brisbane, Australia, January 21, 2026 — Anteris Technologies Global Corp. announced the pricing of a $200...

By cGxPwire Editor
January 21, 2026

MedTech

Anteris Advances DurAVR THV With IDE and Trial Readiness

MINNEAPOLIS & BRISBANE, May 13, 2025—Anteris Technologies Global Corp. announced its first-quarter 2025 results, revealing significant progress across clinical...

By cGxPwire Editor
November 13, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

DurAVR THV

Anteris Raises $200M to Advance Global Heart Valve Trial

Anteris Advances DurAVR THV With IDE and Trial Readiness